Related Experiment Video
Updated: Mar 25, 2026

Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action
Abstract:
Azole antifungal agents (eg, fluconazole and itraconazole) have been widely used to treat superficial fungal infections caused by dermatophytes and, unlike the allylamines (such as terbinafine and naftifine), have been associated with resistance development. Although many published manuscripts describe resistance to azoles among yeast and molds, reports describing resistance of dermatophytes are starting to appear. In this review, I discuss the mode of action of azole antifungals and mechanisms underlying their resistance compared with the allylamine class of compounds. Data from published and original studies were compared and summarized, and their clinical implications are discussed. In contrast to the cidal allylamines, static drugs such as azoles permit the occurrence of mutations in enzymes involved in ergosterol biosynthesis, and the ergosterol precursors accumulating as a consequence of azole action are not toxic. Azole antifungals, unlike allylamines, potentiate resistance development in dermatophytes.
Insights
Azole antifungals, unlike allylamines, promote resistance in dermatophytes. This review explores azole mechanisms of action and resistance, contrasting them with allylamines for better treatment strategies.
Area of Science:
- Mycology
- Dermatology
- Pharmacology
Background:
- Azole antifungal agents (e.g., fluconazole, itraconazole) are common treatments for superficial fungal infections.
- Resistance to azoles is documented in yeasts and molds, with emerging reports in dermatophytes.
- Allylamines (e.g., terbinafine, naftifine) are another class of antifungal agents.
Purpose of the Study:
- To review the mode of action of azole antifungals.
- To elucidate mechanisms of azole resistance in dermatophytes.
- To compare azole resistance with that of allylamine antifungals.
Main Methods:
- Comparative analysis of published and original study data.
- Review of azole antifungal mechanisms of action.
- Examination of ergosterol biosynthesis pathways and resistance mechanisms.
Main Results:
- Azoles are static antifungals, allowing mutations in ergosterol biosynthesis enzymes.
- Accumulating ergosterol precursors from azole action are non-toxic.
- Azoles, unlike cidal allylamines, potentiate resistance development in dermatophytes.
Conclusions:
- Azole antifungals contribute to resistance development in dermatophytes.
- Understanding these mechanisms is crucial for managing superficial fungal infections.
- Further research is needed to optimize antifungal therapies and combat resistance.
Related Concept Videos
Anthelminthic Agents
Antifungal Agents
Antimicrobial Effectiveness
Fungal Phylum Microsporidia
Clinical Significance of Antibiotic Resistance
Acne Infection

